Can hyperactive #DNArepair be targeted in #Neuroendocrine #CervicalCarcinoma?
#Multiomics reveals HRR activation and a CAF–IL6–E2F1–BLM axis that limits #PARP inhibitor sensitivity, supporting dual PARP–BLM inhibition.

Can hyperactive #DNArepair be targeted in #Neuroendocrine #CervicalCarcinoma?
#Multiomics reveals HRR activation and a CAF–IL6–E2F1–BLM axis that limits #PARP inhibitor sensitivity, supporting dual PARP–BLM inhibition.